These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 12476890)
1. Biologic and chemical weapons of mass destruction. Bozeman WP; Dilbero D; Schauben JL Emerg Med Clin North Am; 2002 Nov; 20(4):975-93, xii. PubMed ID: 12476890 [TBL] [Abstract][Full Text] [Related]
2. Medical strategies to handle mass casualties from the use of biological weapons. Koenig KL; Kahn CA; Schultz CH Clin Lab Med; 2006 Jun; 26(2):313-27, viii. PubMed ID: 16815455 [TBL] [Abstract][Full Text] [Related]
3. Operation Castle Cascade: managing multiple casualties from a simulated chemical weapons attack. Siegel D; Younggren BN; Ness B; Kvool V Mil Med; 2003 May; 168(5):351-4. PubMed ID: 12775167 [TBL] [Abstract][Full Text] [Related]
4. Civilian exposure to toxic agents: emergency medical response. Baker D Prehosp Disaster Med; 2004; 19(2):174-8. PubMed ID: 15506255 [TBL] [Abstract][Full Text] [Related]
5. Weapons of mass destruction: the decontamination of children. Rotenberg JS; Burklow TR; Selanikio JS Pediatr Ann; 2003 Apr; 32(4):260-7. PubMed ID: 12723121 [No Abstract] [Full Text] [Related]
6. The effects of weapons of mass destruction on children. Mueller CR J Spec Pediatr Nurs; 2006 Apr; 11(2):114-28. PubMed ID: 16635191 [TBL] [Abstract][Full Text] [Related]
7. Biological and chemical agents: a brief synopsis. Rosenbloom M; Leikin JB; Vogel SN; Chaudry ZA Am J Ther; 2002; 9(1):5-14. PubMed ID: 11782813 [TBL] [Abstract][Full Text] [Related]
8. Medical response to a terrorist attack and weapons of mass destruction. Caldicott DG; Edwards NA; Tingey D; Bonnin R Emerg Med (Fremantle); 2002 Sep; 14(3):230-9. PubMed ID: 12487039 [No Abstract] [Full Text] [Related]
9. Medical aspects of toxin weapons. Bigalke H; Rummel A Toxicology; 2005 Oct; 214(3):210-20. PubMed ID: 16087285 [TBL] [Abstract][Full Text] [Related]
10. Biological and chemical weapons of mass destruction: updated clinical therapeutic countermeasures since 2003. Pettineo C; Aitchison R; Leikin SM; Vogel SN; Leikin JB Am J Ther; 2009; 16(1):35-43. PubMed ID: 22573054 [TBL] [Abstract][Full Text] [Related]
11. Weapons of mass destruction: Overview of the CBRNEs (Chemical, Biological, Radiological, Nuclear, and Explosives). Prockop LD J Neurol Sci; 2006 Nov; 249(1):50-4. PubMed ID: 16920155 [TBL] [Abstract][Full Text] [Related]
12. Credible threat: assessing the likelihood of a chemical or biologic attack. Moores LK; Moores LE Respir Care Clin N Am; 2004 Mar; 10(1):1-8. PubMed ID: 15062223 [TBL] [Abstract][Full Text] [Related]
14. Biomaterials for mediation of chemical and biological warfare agents. Russell AJ; Berberich JA; Drevon GF; Koepsel RR Annu Rev Biomed Eng; 2003; 5():1-27. PubMed ID: 12704086 [TBL] [Abstract][Full Text] [Related]
15. Medical countermeasures to WMDs: defence research for civilian and military use. Hamilton MG; Lundy PM Toxicology; 2007 Apr; 233(1-3):8-12. PubMed ID: 17029736 [TBL] [Abstract][Full Text] [Related]
16. Technological advancements for the detection of and protection against biological and chemical warfare agents. Eubanks LM; Dickerson TJ; Janda KD Chem Soc Rev; 2007 Mar; 36(3):458-70. PubMed ID: 17325785 [TBL] [Abstract][Full Text] [Related]
17. Operation Desert Shield: medical aspects of weapons of mass destruction. Knudson GB Mil Med; 1991 Jun; 156(6):267-71. PubMed ID: 1852275 [TBL] [Abstract][Full Text] [Related]
18. [In-hospital management of victims of chemical weapons of mass destruction]. Barelli A; Gargano F; Proietti R Ann Ist Super Sanita; 2005; 41(1):93-101. PubMed ID: 16037657 [TBL] [Abstract][Full Text] [Related]
19. The role of clinical neurophysiology in bioterrorism. Prakash KM; Lo YL Acta Neurol Scand; 2005 Jan; 111(1):1-6. PubMed ID: 15595931 [TBL] [Abstract][Full Text] [Related]
20. Chemical warfare issues. Hollinger M Crit Care Nurse; 2004 Feb; 24(1):14; author reply 14. PubMed ID: 15007887 [No Abstract] [Full Text] [Related] [Next] [New Search]